Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines
Schneerson, R.; Robbins, J.B.; Barrera, O.; Sutton, A.; Habig, W.B.; Hardegree, M.C.; Chaimovich, J.
Progress in Clinical and Biological Research 47: 77-94
1980
ISSN/ISBN: 0361-7742 PMID: 6970933 Document Number: 155288
Document emailed within 1 workday
Related Documents
Black, S.B.; Shinefield, H.R. 1987: B-CAPSA i Haemophilus influenzae, type b, capsular polysaccharide vaccine safety Pediatrics 79(3): 321-325Wysokińska, T.; Janaszek, W. 1994: Polysaccharide vaccines against Haemophilus influenzae type B Przeglad Epidemiologiczny 48(1-2): 39-44
Adderson, E.E.; Shackelford, P.G.; Quinn, A.; Carroll, W.L. 1991: Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide Journal of Immunology 147(5): 1667-1674
Parkkali, T.; Käyhty, H.; Ruutu, T.; Volin, L.; Eskola, J.; Ruutu, P. 1996: A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT Bone Marrow Transplantation 18(5): 961-967
Henne, G.; Tiller, F.W.; Diener, E. 1984: Quantitation of Haemophilus influenzae serotype b capsular polysaccharide antigen in body fluids by enzyme immunoassay Biomedica Biochimica Acta 43(3): 381-387
Yeh, S.J.; Huang, L.M.; Chen, J.M.; Lee, P.I.; Chang, L.Y.; Lin, Y.J.; Chiu, H.H.; Lee, C.Y. 1997: Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine Journal of the Formosan Medical Association 96(2): 110-115
Lenoir, A.A.; Granoff, P.D.; Granoff, D.M. 1987: Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants Pediatrics 80(2): 283-287
Weinberg, G.A.; Murphy, T.V.; Granoff, D.M. 1990: Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease Pediatrics 86(4): 617-620
Käyhty, H.; Peltola, H.; Eskola, J.; Rönnberg, P.R.; Kela, E.; Karanko, V.; Mäkelä, P.H. 1989: Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age Pediatrics 84(6): 995-999
Rubin, L.G.; Voulalas, D.; Carmody, L. 1989: Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine Pediatrics 84(3): 509-513
Ambrosino, D.M.; Bolon, D.; Collard, H.; Van Etten, R.; Kanchana, M.V.; Finberg, R.W. 1992: Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages Journal of Immunology 149(12): 3978-3983
Lucas, A.H.; Moulton, K.D.; Reason, D.C. 1998: Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide Journal of Immunology 161(7): 3776-3780
Cochi, S.L.; Broome, C.V.; Hightower, A.W. 1985: Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment JAMA 253(4): 521-529
Kerdpanich, A.; Hutagalung, Y.; Watanaveeradej, V.; Bock, H.L.; Steinhoffmd, M. 2007: The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine Journal of the Medical Association of Thailand 90(7): 1330-1336
Yang, C.; Yan, R.; Zeng, W.; Zhang, Y.; Jia, W.; Liu, J.; Zhou, S.; Li, X.; Deng, X. 2003: Experimental study of controlled release microencapsulated Salmonella typhi capsular polysaccharide vaccines immunized mice Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20(4): 626-629
Veronesi, R.; Fayet, M.T.; Stellmann, C.; Takeda, A.K.; Feldman, C.; Focaccia, R.; Mazza, C.C.; Oliveira, C.E.; Sebe, E.; Adelino, M.; Diniz, J.M.; Zuccas, W.A. 1977: Serologic evaluation of the efficiency of meningococcal capsular polysaccharide vaccines of serogroups a and C: correlation with age, dosage, previous immune status and serological assays Revista do Hospital das Clinicas 32(5): 296-305
Cochi, S.L.; Fleming, D.W.; Hull, H.F.; Preblud, S.R.; Orenstein, W.A. 1986: Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine American Journal of Diseases of Children 140(12): 1226-1230
Kristensen, K. 1989: Haemophilus influenzae type b vaccines Ugeskrift for Laeger 151(48): 3216-3218
Rümke, H.C.; Poolman, J.T. 1991: Conjugated vaccines against Haemophilus influenzae type b Nederlands Tijdschrift Voor Geneeskunde 135(1): 4-7
Solberg, C.O.; Brandtzeeg, P. 1995: Vaccine against Haemophilus influenzae type b. a new great achievement in the research on vaccines Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(13): 1597-1598